Cargando…
The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary
Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine tumor of the skin with an estimated disease‐associated mortality of 15–33%. Australia has a higher incidence of MCC compared to the rest of the world, thought to be due to a higher ultraviolet index. The Australian MCC population is d...
Autores principales: | Kok, David L., Wang, Annie, Xu, Wen, Chua, Margaret S. T., Guminski, Alexander, Veness, Michael, Howle, Julie, Tothill, Richard, Kichendasse, Ganessan, Poulsen, Michael, Sandhu, Shahneen, Fogarty, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754344/ https://www.ncbi.nlm.nih.gov/pubmed/32757453 http://dx.doi.org/10.1111/ajco.13407 |
Ejemplares similares
-
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma
por: Weppler, Alison M, et al.
Publicado: (2020) -
Outcome of patient with myasthenia gravis with the use of immunotherapy in metastatic Merkel cell carcinoma
por: Williams, Sarah, et al.
Publicado: (2022) -
Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma
por: Kang, Susan H, et al.
Publicado: (2012) -
Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre
por: Wang, Annie J., et al.
Publicado: (2023) -
Expert commentary: Philip Marsh
por: Marsh, Philip D.
Publicado: (2022)